The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Experience and impact of alopecia in patients (pts) with HER2+ metastatic breast cancer (MBC) in the SystHERs registry.
 
Ginny Mason
Travel, Accommodations, Expenses - Genentech/Roche
 
Musa Mayer
No Relationships to Disclose
 
Sandra M. Swain
Honoraria - Clinigen Group; Roche
Consulting or Advisory Role - Clinigen Group; Genentech/Roche
Research Funding - Genentech; Puma Biotechnology; Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Peter Kaufman
Consulting or Advisory Role - Genentech
Research Funding - Genentech/Roche (Inst)
 
Debu Tripathy
Consulting or Advisory Role - Nektar; Novartis; Oncoplex Diagnostics; Pfizer
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Sara A. Hurvitz
Research Funding - Amgen (Inst); Bayer (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Cascadian Therapeutics (Inst); Dignitana (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Medivation (Inst); Merrimack (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Puma Biotechnology (Inst); sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Lilly; Novartis; OBI Pharma
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Arno Therapeutics; AstraZeneca; Celgene; Eisai; Genentech/Roche; Lilly; Nektar; Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Arno Therapeutics; AstraZeneca; Celgene; Eisai; Genentech/Roche; Lilly; Nektar; Novartis; Pfizer
Travel, Accommodations, Expenses - Abbvie; Celgene; Lilly; Nektar; Novartis; Pfizer
 
Denise A. Yardley
Honoraria - Genentech; Novartis
Research Funding - Genentech (Inst)
 
Adam Brufsky
Consulting or Advisory Role - Agendia; Bayer; bioTheranostics; Celgene; Genentech/Roche; Genomic Health; Lilly; NanoString Technologies; Novartis; Pfizer; Puma Biotechnology
 
Hope S. Rugo
Honoraria - Genomic Health
Speakers' Bureau - Genomic Health
Research Funding - Celsion (Inst); Celsion (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Mylan; Nektar; Novartis; OBI Pharma; Roche/Genentech
 
Melody A. Cobleigh
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline
Research Funding - Genentech/Roche; Macrogenics; Merrimack; NRG Oncology
Patents, Royalties, Other Intellectual Property - Genomic Health
 
Laura Kay Chu
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Vincent P. Antao
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Anne Morris
Employment - Genentech
 
Bongin Yoo
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Mohammad Jahanzeb
Honoraria - Foundation Medicine
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Foundation Medicine
Research Funding - Abbvie (Inst); Genentech/Roche (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Foundation Medicine; Helsinn Therapeutics